Aurinia: Q2 Earnings Snapshot

August 4, 2022 GMT

VICTORIA, British Columbia (AP) _ Aurinia Pharmaceuticals Inc. (AUPH) on Thursday reported a loss of $35.5 million in its second quarter.

On a per-share basis, the Victoria, British Columbia-based company said it had a loss of 25 cents.

The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for a loss of 22 cents per share.

The biotechnology company posted revenue of $28.2 million in the period, beating Street forecasts. Five analysts surveyed by Zacks expected $27.1 million.

Aurinia expects full-year revenue in the range of $115 million to $135 million.

Aurinia shares have decreased 63% since the beginning of the year. The stock has fallen 36% in the last 12 months.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on AUPH at